Effect of valsartan on endothelium-dependent relaxing function in hypertensive patients with and without type 2 diabetes mellitus
Baopeng Tang
Abstract
Baopeng Tang
Abstract
Objective To investigate the changes of endothelium - dependent relaxing function in hypertensive patients with and without type 2 diabetes mellitus ( EH + DM vs. EH) and the effect of valsartan on it. Methods With high-resolution ultrasound, the change of diameters in brachial arteries in responding to reactive hyperemia (ΔD% ) were measured in 34 patients with EH and 28 patients with EH + DM pre and post treatment of valsartan. Results In patients with EH + DM, the ΔD% was much reduced compared with that in EH group [ ( 2. 50±4. 00 ) % vs. ( 6. 34± 4. 34 ) % , P 0. 05] , while after being treated with valsartan for 12 weeks, the ΔD% was ameliorated than that pre treatment [ (4. 68±3. 22)% vs. (2.50±4.00)%, (10.12±4.68)% vs. (6.34±4.34)% , P 0. 05]. Conclusion Hypertensive patients with type 2 diabetes mellitus suffered more serious functional impairment of endothelium-dependent vasodilation than those without type 2 diabetes mellitus, and these dysfunction may be ameliorated by treatment of valsartan.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the changes of endothelium - dependent relaxing function in hypertensive patients with and without type 2 diabetes mellitus ( EH + DM vs. EH) and the effect of valsartan on it. Methods With high-resolution ultrasound, the change of diameters in brachial arteries in responding to reactive hyperemia (ΔD% ) were measured in 34 patients with EH and 28 patients with EH + DM pre and post treatment of valsartan. Results In patients with EH + DM, the ΔD% was much reduced compared with that in EH group [ ( 2. 50±4. 00 ) % vs. ( 6. 34± 4. 34 ) % , P 0. 05] , while after being treated with valsartan for 12 weeks, the ΔD% was ameliorated than that pre treatment [ (4. 68±3. 22)% vs. (2.50±4.00)%, (10.12±4.68)% vs. (6.34±4.34)% , P 0. 05]. Conclusion Hypertensive patients with type 2 diabetes mellitus suffered more serious functional impairment of endothelium-dependent vasodilation than those without type 2 diabetes mellitus, and these dysfunction may be ameliorated by treatment of valsartan.
Key concepts: Valsartan, Medicine, Internal medicine, Diabetes mellitus, Endothelium, Type 2 Diabetes Mellitus, Reactive hyperemia, Essential hypertension